The iconic rise of Viagra has long been a symbol of pharmaceutical success, however its legacy within the broader industry now presents questions about long-term yields . Alternative versions are eroding market share, leading to worries that investing in companies closely tied to Viagra's former influence could be a speculative decision , especiall